Ambiq Micro (NYSE:AMBQ) Announces Quarterly Earnings Results

Ambiq Micro (NYSE:AMBQGet Free Report) announced its quarterly earnings results on Tuesday. The company reported ($0.07) EPS for the quarter, FiscalAI reports. The firm had revenue of $33.90 million during the quarter. Ambiq Micro had a negative net margin of 37.77% and a negative return on equity of 15.22%. Ambiq Micro updated its Q3 2026 guidance to -0.200–0.120 EPS.

Here are the key takeaways from Ambiq Micro’s conference call:

  • Second-quarter sales reached $33.9 million, up 89.7% year over year and ahead of guidance, while non-GAAP gross profit more than doubled and gross margin improved to 47.2%.
  • Management raised its full-year 2026 sales outlook to approximately $135 million and expects third-quarter revenue of $36 million-$37 million, supported by accelerating edge-AI demand and continued customer product ramps.
  • Demand is exceeding available capacity across wafers, packaging, substrates, and testing, constraining second-half revenue; management is seeking additional foundry and OSAT capacity, with some demand deferred until supply improves.
  • Ambiq reported strong momentum for new Apollo3 Blue Plus and Apollo510 Lite products, broader adoption in medical, industrial, and smart-home markets, and continued development of Atomiq 110 and Apollo 340, targeted for customer sampling in early 2027.
  • The company ended the quarter with $366.8 million in cash and no debt after raising roughly $168 million in its latest offering, but it plans to continue investing heavily in product development, including $7 million-$10 million of 2026 IP purchases, and did not provide a timeline for profitability or cash-flow breakeven.

Ambiq Micro Trading Up 3.8%

NYSE AMBQ traded up $2.51 during trading on Thursday, reaching $68.10. The company’s stock had a trading volume of 45,245 shares, compared to its average volume of 509,425. The stock has a market capitalization of $1.46 billion and a PE ratio of -32.28. The business has a 50-day moving average price of $76.89 and a 200-day moving average price of $52.49. Ambiq Micro has a 1-year low of $22.12 and a 1-year high of $91.61.

Insider Buying and Selling at Ambiq Micro

In other news, Director Timothy Chen sold 70,592 shares of the stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $79.79, for a total transaction of $5,632,535.68. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, COO Sean Chihhsiang Chen sold 55,685 shares of the firm’s stock in a transaction on Friday, May 15th. The shares were sold at an average price of $70.89, for a total transaction of $3,947,509.65. Following the transaction, the chief operating officer owned 120,275 shares in the company, valued at $8,526,294.75. This represents a 31.65% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 10.00% of the company’s stock.

Hedge Funds Weigh In On Ambiq Micro

A number of institutional investors and hedge funds have recently bought and sold shares of AMBQ. Barclays PLC lifted its holdings in shares of Ambiq Micro by 28.7% during the fourth quarter. Barclays PLC now owns 8,451 shares of the company’s stock valued at $241,000 after acquiring an additional 1,883 shares during the period. Los Angeles Capital Management LLC bought a new stake in shares of Ambiq Micro in the 4th quarter worth about $257,000. Alyeska Investment Group L.P. acquired a new stake in shares of Ambiq Micro during the 3rd quarter worth about $560,000. Bank of America Corp DE bought a new position in Ambiq Micro during the 3rd quarter valued at about $177,000. Finally, Two Sigma Investments LP bought a new position in Ambiq Micro during the 3rd quarter valued at about $223,000.

Analyst Ratings Changes

AMBQ has been the subject of several research reports. Citigroup reissued a “neutral” rating on shares of Ambiq Micro in a research note on Tuesday. Needham & Company LLC boosted their price objective on Ambiq Micro from $70.00 to $85.00 and gave the stock a “buy” rating in a report on Wednesday. Weiss Ratings reiterated a “sell (d-)” rating on shares of Ambiq Micro in a report on Monday, June 29th. Zacks Research raised shares of Ambiq Micro from a “strong sell” rating to a “hold” rating in a research report on Monday, May 4th. Finally, UBS Group set a $85.00 price target on shares of Ambiq Micro in a research report on Wednesday. Four equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $76.00.

Check Out Our Latest Research Report on Ambiq Micro

About Ambiq Micro

(Get Free Report)

Ambiq Micro (NYSE: AMBQ) is a semiconductor company specializing in the design and development of ultra-low-power microcontroller units (MCUs) and application-specific integrated circuits (ASICs). The company’s core technology leverages sub-threshold voltage operation to dramatically reduce energy consumption, enabling extended battery life in a broad range of portable and always-on devices. Ambiq’s products are particularly well suited for applications where power efficiency is critical, such as wearable electronics, IoT sensors, medical monitoring equipment, and industrial automation systems.

The company’s flagship product family, the Apollo series of MCUs, offers multi-core architectures, integrated wireless connectivity options, and advanced security features.

Recommended Stories

Receive News & Ratings for Ambiq Micro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambiq Micro and related companies with MarketBeat.com's FREE daily email newsletter.